Shao-Lee Lin

Acelyrin raises $250M, licenses antibody drug that could rival Novartis, Lilly meds

Acelyrin has in-licensed izokibep, an antibody drug developed by Affibody that could offer advantages compared to currently available monoclonal antibodies. The drug addresses the same target as blockbuster immunology drugs marketed by Novartis and Eli Lilly.

By Frank Vinluan

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

By PurpleLab

What’s Keeping Healthcare CIOs Up at Night: How Health Systems Automate Routine Phone Calls to Improve Workforce Effectiveness and Reduce Agent Burnout

With hospitals struggling to retain staff and value-based care shrinking healthcare revenues, health systems must look to technology resources to become more efficient, without losing sight of patient care or staff support.